Página 1 a partir de 26 resultados
RELATED APPLICATIONS
This application is a U.S. National Phase application, filed under 35 U.S.C. .sctn. 371(c), of International Application No. PCT/GB2016/050998, filed on Apr. 11, 2016, which claims the benefit of and priority to United Kingdom Patent Application No. 1506116.1, filed on Apr. 10,
BACKGROUND OF INVENTION
1. Field of the Invention
The present invention relates to a novel method of administering anti nausea and anti emetic agents and to novel dosage forms containing such agents adapted for nasal administration.
The invention provides a novel method of administering therapeutic
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to novel nutritional anti-nausea compositions, anti-emetic compositions and methods of using the same to provide relief from nausea and/or vomiting. The present compositions are also nonteratogenic and are
This application is a National Stage Application of PCT/IN2008/000704, filed Oct. 24, 2008, which claims benefit of Serial No. 1460/KOL/2007, filed Oct. 25, 2007 in India and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of
FIELD OF THE INVENTION
The present invention relates to both a therapeutic composition comprising a combination of antiemetic drugs and to a method for treating emesis, including nausea.
BACKGROUND OF THE INVENTION
Nausea and vomiting can follow the administration of many drugs, particularly
FIELD OF THE INVENTION
This invention is in the field of pharmacology, and relates to anti-emetic drugs, i.e., drugs that suppress nausea and vomiting.
BACKGROUND OF THE INVENTION
"Emesis" and "emetic" refer to the process commonly known as vomiting or retching, wherein the stomach is evacuated
FIELD OF THE INVENTION
This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching.
BACKGROUND OF THE INVENTION
Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the
FIELD OF THE INVENTION
This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching.
BACKGROUND OF THE INVENTION
Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the
FIELD OF THE INVENTION
This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching.
BACKGROUND OF THE INVENTION
Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the
FIELD OF THE INVENTION
This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching.
BACKGROUND OF THE INVENTION
Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the
FIELD OF THE INVENTION
This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching.
BACKGROUND OF THE INVENTION
Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the
BACKGROUND OF THE INVENTION
This invention is concerned with compounds of structural formula I: ##STR1## wherein X is --CH.dbd.CH--, --CH.sub.2 --CH.sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --S--CH.sub.2 --, --CH.sub.2 --S--, --S-- or --O--, and R is a 5- or 6-membered nitrogen heterocyclic
BACKGROUND OF THE INVENTION
This invention is concerned with compounds of structural formula I: ##STR1## wherein X is --CH.dbd.CH--, --CH.sub.2 --CH.sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --S--CH.sub.2 --, --CH.sub.2 --S--, --S-- or --O--, and R is a 5- or 6-membered nitrogen heterocyclic
CROSS-REFERENCE TO RELATED APPLICATIONS
Not applicable.
STATEMENT REGARDING FEDERALLY SPONSERED RESEARCH OR DEVELOPMENT
Not applicable.
REFERENCE TO A MICROFICHE APPENDIX
Not applicable.
BACKGROUND OF THE INVENTION
1. Field of the Invention
A new use for estrone, derivatives of estrone, equilin and
This invention relates to a method of treatment and/or prophylaxis of nausea and vomiting, comprising the administration of a compound having 5-HT.sub.3 receptor antagonist activity.
EP-A-200444 (Beecham Group p.l.c.), Example 6 discloses granisetron, and its use as an anti-emetic, especially useful